AstraZeneca CEO teases weight-loss drug candidate as profit meets target
The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesThe pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.
The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.
Earnings season marches on. Two more Magnificent Seven tech companiesâEUR"Alphabet and AmazonâEUR"will report this week, following on the heels of disappoi...
South Korean automaker and pharmaceutical stocks were falling after President Donald Trump late Monday threatened to raise tariffs on some Korean imports t...
Canadian pharmacy platform to offer India-sourced Ozempic to US patients
SAN FRANCISCO, January 08, 2026--Biotech Showcase(TM) Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma...
AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit
Top China Pharma and Biotech Stocks to Watch, According to Bernstein
The latest investor updates on stocks that are trending on Wednesday.
Can Fite Biopharma stock soars on Brazil patent grant for sexual dysfunction
Can Fite Biopharma stock tumbles after announcing 1-for-3,000 reverse split
Top 4 Large-Cap US Pharma Stocks for 2026, According to JP Morgan